Antimicrobial resistance and infection control
8 European H2020 organizations list this as part of their work — 4 as their primary capability.
Most active in this area
- UNIVERSITATEA DE MEDICINA SI FARMACIE CAROL DAVILA DIN BUCURESTI
Romania's top medical university, contributing clinical expertise in elderly care, antimicrobial resistance, and AI-driven health monitoring to European research consortia.
“REVERSE (EUR 1.25M — their largest grant by far) targets AMR prevention and antibiotic stewardship in high-prevalence healthcare settings.”
PrimaryRO9 projects - SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST
Major UK NHS teaching hospital providing clinical validation sites, patient cohorts, and real-world healthcare data for European digital health and medical research projects.
“ANTI-SUPERBUGS PCP addresses hospital-acquired infections through pre-commercial procurement of innovative solutions.”
UK7 projects - FUNDACION PARA LA INVESTIGACION BIOMEDICA DE CORDOBA
Córdoba-based biomedical research foundation specialising in antimicrobial resistance, precision medicine, and clinical infectious disease research across European consortia.
“Active in both ECRAID-Base (infectious disease clinical research network) and REVERSE (AMR prevention in high-prevalence settings).”
PrimaryES6 projects - AZIENDA PROVINCIALE PER I SERVIZI SANITARI
Italian provincial health authority providing clinical sites, patient cohorts, and real-world validation for digital health and oncology research.
“ANTI-SUPERBUGS PCP involved pre-commercial procurement of solutions to combat drug-resistant infections in hospital settings.”
IT4 projects - AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA
Italian university hospital contributing clinical data, patient cohorts, and pharmacy expertise to European infectious disease and drug quality research.
“REVERSE targets AMR prevention, antibiotic stewardship, and healthcare-associated infection management in high-prevalence hospital settings.”
PrimaryIT4 projects - THE FOUNDATION FOR MEDICAL RESEARCH INFRASTRUCTURAL DEVELOPMENT AND HEALTH SERVICES NEXT TO THE MEDICAL CENTER TEL AVIV
Israeli teaching hospital research foundation specializing in digital health monitoring, mental resilience, sleep neuroscience, and antimicrobial resistance within large European clinical consortia.
“REVERSE (2021) addresses antibiotic stewardship, infection prevention, and healthcare-associated infections in high-prevalence settings.”
IL4 projects - FUNDACIO INSTITUT D'INVESTIGACIO SANITARIA ILLES BALEARS
Balearic Islands health research institute specializing in antimicrobial resistance, nanotechnology-based infection therapeutics, and autoimmune disease genomics.
“Both REBELLION (nanotechnology-based pathogen eradication) and AmReSu (AMR surveillance with whole genome sequencing) directly address antimicrobial resistance from complementary angles.”
PrimaryES3 projects - Fundación para la Gestión de la Investigación Biomédica de Cádiz
Spanish biomedical foundation specialising in neonatal neurodevelopment, AI-based diagnostics, and antimicrobial resistance research within regional clinical settings.
“FGIBICA joined REVERSE (2021–2026) as a third party, signalling entry into antibiotic stewardship and healthcare-associated infection prevention research.”
ES2 projects